Introduction Nitrosamine Testing for Veterinary Drug Products is a critical analytical quality control process used to identify and quantify mutagenic […]
Introduction Bioanalytical Method Transfer Services provide a structured and well-documented approach for transferring validated analytical methods between laboratories while maintaining
Introduction: The Etanercept Biosimilar Higher-Order Structure is one of the most critical attributes evaluated during biosimilar development because even subtle
Introduction Post-Approval Changes for Approved Biosimilars require a structured, science-driven comparability assessment conducted in accordance with the ICH Q5E framework
Post-Approval Changes for Approved Biosimilars: Comparability Requirements Under ICH Q5E Read More »
Introduction: Setting a therapeutic peptide API purity specification is one of the most consequential — and most frequently misjudged —
Introduction The regulatory framework governing Extrapolation of Indications in Biosimilar Approval is a well-established, science-driven approach that enables a biosimilar
PLGA Microsphere Formulation Development — Case Study Redesign :root{ –ink:#101d2b; –paper:#f6f5f1; –panel:#ffffff; –teal:#1b6e71; –teal-dim:#e4eeed; –amber:#b8802e; –amber-dim:#f4e9da; –slate:#57626e; –line:#e1ddd2; –line-dark:#28394a; }
Case Study: PLGA Microsphere Formulation Development for a 3-Month Depot Antipsychotic Read More »
Introduction: Bioequivalence study bioanalytical services are the laboratory backbone of every generic drug approval, formulation change, and lifecycle management submission
Introduction Nitrosamine Risk in Drug-Drug Combination Products has emerged as a significant toxicological challenge because combining multiple active pharmaceutical ingredients
Introduction Antisense Oligonucleotide-Peptide Conjugates have emerged as an advanced therapeutic platform designed to address the longstanding pharmacokinetic, biodistribution, and intracellular
